People · Operator
Named in public records as an officer, director or promoter · active 2009–2011 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DMI Life Sciences, Inc. | — | Biotechnology | Seed | $2.2M | $53.7M | 2009 |
| Ampio Pharmaceuticals, Inc. | — | Pharmaceuticals | Pre-Seed | $585K | $27.7M | 2011 |
Bruce G Miller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bruce G Miller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Macaluso | 2 | 4 |
| Philip H. Coelho | 1 | 2 |
| Vaughan H Clift | 1 | 1 |
| Donald B Wingerter, Jr. | 1 | 1 |
| David B Bar-Or | 1 | 1 |
| Wannell Crook | 1 | 1 |
| James Winkler | 1 | 1 |
| Raphael Bar-Or | 1 | 1 |
| David Bar-Or | 1 | 1 |
| Richard H Giles | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.